Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma

Published:2016-08 Issue:2 Volume:65 Page:296-304
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Zhu Andrew X.,Chen David,He Wei,Kanai Masayuki,Voi Maurizio,Chen Li-Tzong,Daniele Bruno,Furuse Junji,Kang Yoon-Koo,Poon Ronnie T.P.,Vogel Arndt,Chiang Derek Y.

Publisher

Elsevier BV

Subject

Hepatology

Reference56 articles.

1. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

3. Advances in targeted therapies for hepatocellular carcinoma in the genomic era;Llovet;Nat Rev Clin Oncol,2015

4. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma;Arao;Hepatology,2013

5. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design;Llovet;Clin Cancer Res,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation analysis of PPP2R1A gene expression and immune infiltration in hepatocellular carcinoma;2023-12-06

2. Magnetic Metal–Organic Framework-Based Nanoplatform with Platelet Membrane Coating as a Synergistic Programmed Cell Death Protein 1 Inhibitor against Hepatocellular Carcinoma;ACS Nano;2023-11-22

3. Prognostic Significance of ZP3 in Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2023-08

4. Hepatocellular carcinoma;The Lancet;2022-10

5. LncCDCA3L inhibits cell proliferation via a novel RNA structure‐based crosstalk with CDCA3 in hepatocellular carcinoma;Liver International;2022-03-11